Market Overview

Citi Reiterates Sell on Athenahealth


Citi reiterated its Sell rating on Athenahealth (NASDAQ: ATHN) after a meeting with the company's management.

In a research report published today, Citi states, "Our meeting... reinforced our belief that in the near term hospitals will resist this painful change, which could slow the development of the Athena enterprise sales pipeline. A lack of enterprise sales could lead to disappointing utilization trends and negative revisions."

At the moment, Citi has a price target of $40 placed on the company's stock. On Friday, the company lost 1.69% of its value to close the week at $42.01.


Related Articles (ATHN)

View Comments and Join the Discussion!

Posted-In: athenahealth CitiAnalyst Color Analyst Ratings

Latest Ratings

BIIBRBC CapitalMaintains277.0
RLICompass PointInitiates Coverage On90.0
CSCOWolfe ResearchDowngrades42.0
GILDRBC CapitalMaintains86.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at